ARZERRA (ofatumumab)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · CHRONIC LYMPHOCYTIC LEUKEMIA ·+2
Novartis Pharmaceuticals
All drugs.
Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.
Enter at least 3 characters to search the full directory.
Results
MEKINIST (trametinib dimethyl sulfoxide)
ANTINEOPLASTIC - MEK1 AND MEK2 KINASE INHIBITORS · MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+5
Novartis Pharmaceuticals
PROMACTA (eltrombopag olamine)
THROMBOPOIETIC GROWTH FACTORS · APLASTIC ANEMIA ·+2
Novartis Pharmaceuticals
TAFINLAR (dabrafenib mesylate)
ANTINEOPLASTIC - BRAF KINASE INHIBITORS · MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+5
Novartis Pharmaceuticals
TYKERB (lapatinib ditosylate)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · HER2-POSITIVE CARCINOMA OF BREAST ·+1
Novartis Pharmaceuticals
VOTRIENT (pazopanib HCl)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · SOFT OR CONNECTIVE TISSUE SARCOMA ·+1
Novartis Pharmaceuticals
ARRANON (nelarabine)
T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ·+1
Novartis Pharmaceuticals
HYCAMTIN (topotecan HCl)
SMALL CELL LUNG CARCINOMA ·+3
Novartis Pharmaceuticals
RECLAST (zoledronic acid in mannitol and water for injection)
PAGET'S DISEASE OF BONE ·+5
Novartis Pharmaceuticals
ILARIS (canakinumab/PF)
ANTI-INFLAMMATORY - INTERLEUKIN 1 RECEPTOR ANTAGONIST · ACUTE GOUTY ARTHRITIS ·+7
Novartis Pharmaceuticals
KISQALI (ribociclib succinate)
ANTINEOPLASTIC- CYCLIN-DEPENDENT KINASE (CDK) 4/6 INHIBITORS · HORMONE RECEPTOR (HR)-POSITIVE, HER2-NEGATIVE ADVANCED BREAST CANCER ·+1
Novartis Pharmaceuticals
HYCAMTIN (topotecan HCl)
SMALL CELL LUNG CARCINOMA
Novartis Pharmaceuticals
RYDAPT (midostaurin)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ACUTE MYELOID LEUKEMIA WITH FMS-LIKE TYROSINE KINASE-3 (FLT3) MUTATION ·+3
Novartis Pharmaceuticals
KISQALI FEMARA CO-PACK (ribociclib succinate/letrozole)
HORMONE RECEPTOR (HR)-POSITIVE, HER2-NEGATIVE ADVANCED BREAST CANCER ·+1
Novartis Pharmaceuticals
JADENU SPRINKLE (deferasirox)
IRON CHELATING AGENTS · CHRONIC IRON OVERLOAD DUE TO REPEATED BLOOD TRANSFUSIONS ·+1
Novartis Pharmaceuticals
KYMRIAH (tisagenlecleucel)
ANTINEOPLASTIC - CAR-T/TCR-T CELL IMMUNOTHERAPY · B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Novartis Pharmaceuticals
ZOFRAN (ondansetron HCl)
PREVENTION OF POST-OPERATIVE NAUSEA AND VOMITING ·+2
Novartis Pharmaceuticals
ARGATROBAN
THROMBOSIS IN HEPARIN-INDUCED THROMBOCYTOPENIA ·+2
Novartis Pharmaceuticals
PROMACTA (eltrombopag olamine)
THROMBOPOIETIC GROWTH FACTORS · APLASTIC ANEMIA ·+2
Novartis Pharmaceuticals
MAYZENT (siponimod)
MULTIPLE SCLEROSIS AGENTS, GENERAL · RELAPSING FORM OF MULTIPLE SCLEROSIS
Novartis Pharmaceuticals
MAYZENT (siponimod)
MULTIPLE SCLEROSIS AGENTS, GENERAL · RELAPSING FORM OF MULTIPLE SCLEROSIS
Novartis Pharmaceuticals
ZYKADIA (ceritinib)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ANAPLASTIC LYMPHOMA KINASE POSITIVE NON-SMALL CELL LUNG CANCER
Novartis Pharmaceuticals
EGATEN (triclabendazole)
ANTHELMINTICS · FASCIOLIASIS
Novartis Pharmaceuticals
PIQRAY (alpelisib)
ANTINEOPLASTIC - PHOSPHATIDYLINOSITOL 3-KINASE ALPHA INHIB. · HORMONE RECEPTOR (HR)-POSITIVE, HER2-NEGATIVE, PIK3CA MUTATED ADVANCED BREAST CANCER
Novartis Pharmaceuticals
ZOLGENSMA (onasemnogene abeparvovec-xioi)
SPINAL MUSCULAR ATROPHY
Novartis Pharmaceuticals